The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
The hypercoagulable state in thalassemia
Abstract
Thalassemia is a congenital hemolytic disorder caused by a partial or complete deficiency of α- or β-globin chain synthesis. Homozygous carriers of β-globin gene defects suffer from severe anemia and other serious complications from early childhood. The disease is treated by chronic blood transfusion. However, this can cause severe iron overload resulting in progressive organ failure. Some forms of α thalassemia are also associated with a similar clinical picture. Despite the difficulties associated with treatment, standards of care for thalassemic patients have improved in recent years, resulting in almost doubling of the average life expectancy. As a consequence, additional previously undescribed, complications are now being recognized. In particular, profound hemostatic changes have been observed in patients with β-thalassemia major (β-TM) and β-thalassemia intermedia (β-TI) and also in patients with α thalassemia (hemoglobin H disease). The presence of a higher than normal incidence of thromboembolic events, mainly in β-TI, and the existence of prothrombotic hemostatic anomalies in the majority of the patients, even from a very young age, have led to the recognition of the existence of a chronic hypercoagulable state in thalassemic patients. Despite the appearance of numerous publications on the frequent occurrence of thromboembolic complications in thalassemia, this complication has not been emphasized or comprehensively reviewed. This review summarizes the current literature and discusses possible mechanisms of the lifelong hypercoagulable state that exists in thalassemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Platelet Activation in Unstable Coronary Disease
Fitzgerald, D. J., Roy, L., Catella, F., & FitzGerald, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610163151602 · Cited by 1,141
Olivieri, N. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907083410207 · Cited by 728
Circulating Activated Endothelial Cells in Sickle Cell Anemia
Solovey, A., Lin, Y., Browne, P., Choong, S., Wayner, E., & Hebbel, R. P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372203 · Cited by 628
Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus
Davì, G., Catalano, I., Averna, M., Notarbartolo, A., Strano, A., Ciabattoni, G., & Patrono, C. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006213222503 · Cited by 597
Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet Activation
FitzGerald, G. A., Smith, B., Pedersen, A. K., & Brash, A. R. (1984) · New England Journal of Medicine · doi:10.1056/nejm198404263101701 · Cited by 497
Transgenic Knockout Mice with Exclusively Human Sickle Hemoglobin and Sickle Cell Disease
Pászty, C., Brion, C. M., Manci, E., Witkowska, H. E., Stevens, M. E., Mohandas, N., & Rubin, E. M. (1997) · Science · doi:10.1126/science.278.5339.876 · Cited by 467
Clinical Implications of Prostaglandin and Thromboxane A2Formation
Oates, J. A., FitzGerald, G. A., Branch, R. A., Jackson, E. K., Knapp, H. R., & Roberts, L. J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809223191206 · Cited by 444
Clinical Implications of Prostaglandin and Thromboxane A2Formation
Oates, J. A., FitzGerald, G. A., Branch, R. A., Jackson, E. K., Knapp, H. R., & Roberts, L. J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809153191106 · Cited by 379
Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions
Pegelow, C. H., Adams, R. J., McKie, V., Abboud, M., Berman, B., Miller, S. T., Olivieri, N., Vichinsky, E., Wang, W., & Brambilla, D. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70204-0 · Cited by 367
Belcher, J. D., Marker, P. H., Weber, J. P., Hebbel, R. P., & Vercellotti, G. M. (2000) · Blood · doi:10.1182/blood.v96.7.2451 · Cited by 367
Survival and Disease Complications in Thalassemia Major
BORGNA‐PIGNATTI, C., RUGOLOTTO, S., DE STEFANO, P., PIGA, A., DI GREGORIO, F., GAMBERINI, M. R., SABATO, V., MELEVENDI, C., CAPPELLINI, M. D., & VERLATO, G. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10479.x · Cited by 343
Transbilayer movement of phospholipids in red cell and platelet membranes
Schroit, A. J., & Zwaal, R. F. A. (1991) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(91)90019-s · Cited by 313
Silent cerebral infarcts in sickle cell anemia: a risk factor analysis
Kinney, T. R., Sleeper, L. A., Wang, W. C., Zimmerman, R. A., Pegelow, C. H., Ohene-Frempong, K., Wethers, D. L., Bello, J. A., Vichinsky, E. P., Moser, F. G., et al. (1999) · PEDIATRICS · doi:10.1542/peds.103.3.640 · Cited by 309
Knockout-Transgenic Mouse Model of Sickle Cell Disease
Ryan, T. M., Ciavatta, D. J., & Townes, T. M. (1997) · Science · doi:10.1126/science.278.5339.873 · Cited by 300
Kuypers, F., Lewis, R., Hua, M., Schott, M., Discher, D., Ernst, J., & Lubin, B. (1996) · Blood · doi:10.1182/blood.v87.3.1179.bloodjournal8731179 · Cited by 297
Cappellini, M. D., Robbiolo, L., Bottasso, B. M., Coppola, R., Fiorelli, G., & Mannucci, A. P. M. (2000) · British Journal of Haematology · doi:10.1111/j.1365-2141.2000.02376.x · Cited by 297
Connor, J., Pak, C. C., & Schroit, A. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41959-4 · Cited by 289
Stroke Prevention Trial in Sickle Cell Anemia
Adams, R. J., McKie, V. C., Brambilla, D., Carl, E., Gallagher, D., Nichols, F. T., Roach, S., Abboud, M., Berman, B., Driscoll, C., et al. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00099-8 · Cited by 278
Bernaudin, F., Verlhac, S., Fréard, F., Roudot-Thoraval, F., Benkerrou, M., Thuret, I., Mardini, R., Vannier, J. P., Ploix, E., Romero, M., et al. (2000) · Journal of Child Neurology · doi:10.1177/088307380001500510 · Cited by 248
Thrombogenesis in sickle cell disease
Tomer, A., Harker, L. A., Kasey, S., & Eckman, J. R. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.115450 · Cited by 222
Tissue factor expression by endothelial cells in sickle cell anemia.
Solovey, A., Gui, L., Key, N. S., & Hebbel, R. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1932 · Cited by 222
THROMBO‐EMBOLIC DISEASE AFTER SPLENECTOMY FOR HEREDITARY STOMATOCYTOSIS
Stewart, G. W., Amess, J. A. L., Eber, S. W., Kingswood, C., Lane, P. A., Smith, B. D., & Mentzer, W. C. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.4881033.x · Cited by 210
Membrane Phospholipid Asymmetry in Human Thalassemia
Kuypers, F. A., Yuan, J., Lewis, R. A., Snyder, L. M., Kiefer, C. R., Bunyaratvej, A., Fucharoen, S., Ma, L., Styles, L., de Jong, K., et al. (1998) · Blood · doi:10.1182/blood.v91.8.3044.3044_3044_3051 · Cited by 204
Thromboembolic Events in Beta Thalassemia Major: An Italian Multicenter Study
Borgna Pignatti, C., Carnelli, V., Caruso, V., Dore, F., De Mattia, D., Di Palma, A., Di Gregorio, F., Romeo, M. A., Longhi, R., Mangiagli, A., et al. (1998) · Acta Haematologica · doi:10.1159/000040814 · Cited by 192
Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin
Manodori, A. B., Barabino, G. A., Lubin, B. H., & Kuypers, F. A. (2000) · Blood · doi:10.1182/blood.v95.4.1293.004k42_1293_1300 · Cited by 190
Yashar, V. B., Barenholz, Y., Hy‐Am, E., Rachmilewitz, E. A., & Eldor, A. (1993) · American Journal of Hematology · doi:10.1002/ajh.2830440114 · Cited by 166
Self-citationCardiopulmonary Assessment in Beta-Thalassemia Major
Grisaru, D., Rachmilewitz, E. A., Mosseri, M., Gotsman, M. S., Lafair, J. S., Okon, E., Goldfarb, A., & Hasin, Y. (1990) · CHEST Journal · doi:10.1378/chest.98.5.1138 · Cited by 155
Self-citationTait, J. F., & Gibson, D. (1994) · PubMed · Cited by 152
Sultana, C., Shen, Y. M., Rattan, V., Johnson, C. S., & Kalra, V. K. (1998) · Blood · doi:10.1182/blood.v92.10.3924 · Cited by 137
Pulmonary hypertension in patients with thalassemia major
Du, Z.-D., Roguin, N., Milgram, E. A., Saab, K., & Koren, A. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)70091-7 · Cited by 134
Ruf, A., Pick, M., Deutsch, V. R., Patscheke, H., Goldfarb, A. W., Rachmilewitz, E. A., Guillin, M. C., & Eldor, A. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.1502965.x · Cited by 130
Self-citationEldor, A., Durst, R. Y., Hyam, E., Goldfarb, A. W., Gillis, S., Rachmilewitz, E. A., Abramov, A., Maclouf, J., Godefray, Y. C., de Raucourt, E., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01758.x · Cited by 128
Self-citationFrancis, R. B. (1991) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199104000-00018 · Cited by 123
Pulmonary hypertension in patients with thalassemia major
Derchi, G., Fonti, A., Forni, G. L., Galliera, E. O. O., Cappellini, M. D., & Turati, F. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70129-8 · Cited by 123
Mannu, F., Arese, P., Cappellini, M. D., Fiorelli, G., Cappadoro, M., Giribaldi, G., & Turrini, F. (1995) · Blood · doi:10.1182/blood.v86.5.2014.bloodjournal8652014 · Cited by 112
Helley, D., Eldor, A., Girot, R., Ducrocq, R., Guillin, M., & Bezeaud, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650577 · Cited by 108
Self-citationEldor, A., Lellouche, F., Goldfarb, A. W., Rachmilewitz, E. A., & Maclouf, J. (1991) · Blood · doi:10.1182/blood.v77.8.1749.1749 · Cited by 103
Self-citationMechanism and function of changes in membrane-phospholipid asymmetry in platelets and erythrocytes
Zwaal, R. F. A., Comfurius, P., & Bevers, E. M. (1993) · Biochemical Society Transactions · doi:10.1042/bst0210248 · Cited by 96
Enhanced thrombin generation in children with sickle cell disease.
Peters, M., Plaat, B. E. C., Cate, H. T., Wolters, H. J., Weening, R. S., & Brandjes, D. P. M. (1994) · PubMed · Cited by 93
Thalassemia major (homozygous beta‐thalassemia)
Logothetis, J. A., Constantoulakis, M., Economidou, J., et al. (1972) · Neurology · doi:10.1212/wnl.22.3.294 · Cited by 92
Enhanced aggregability of red blood cells of beta-thalassemia major patients
Chen, S., Eldor, A., Barshtein, G., Zhang, S., Goldfarb, A. W., Rachmilewitz, E. A., & Yedgar, S. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.6.h1951 · Cited by 91
Self-citationEnhanced adherence of β‐thalassaemic erythrocytes to endothelial cells
Hovav, Goldfarb, Artmann, Yedgar, & Barshtein (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01489.x · Cited by 84
Manfrè, L., Giarratano, E., Maggio, A., Banco, A., Vaccaro, G., & Lagalla, R. (1999) · American Journal of Roentgenology · doi:10.2214/ajr.173.6.10584785 · Cited by 80
Cappellini, M. D., Tavazzi, D., Duca, L., Graziadei, G., Mannu, F., Turrini, F., Arese, P., & Fiorelli, G. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01217.x · Cited by 77
Wolters, H. J., Cate, H. T., Thomas, L. L. M., BRANDIES, D. P. M., van den Ende, A., HEIDEN, Y. V. D., & van Eps, L. W. S. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05607.x · Cited by 58
PADGEM/GMP‐140 expression on platelet membranes from homozygous beta thalassaemic patients
Principe, D. D., Menichelli, A., Giulio, S. D., Matteis, W. D., Cianciulli, P., & Papa, G. F. S. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb03033.x · Cited by 54
Erythrocyte-endothelial cell adherence in sickle cell disorders
Smith, B., & Celle, P. L. (1986) · Blood · doi:10.1182/blood.v68.5.1050.1050 · Cited by 50
Possible evidence of endothelial cell activation and disturbance in thalassemia: an in vitro study.
Butthep, P., Bunyaratvej, A., Funahara, Y., et al. (1997) · PubMed · Cited by 48
Right ventricular cardiac dysfunction in beta-thalassemia major.
Koren, A., Garty, I., Antonelli, D., et al. (1987) · PubMed · Cited by 42
Hassoun, H., Wang, Y., Vassiliadis, J., Lutchman, M., Palek, J., Aish, L. S., Aish, I. S., Liu, S., & Chishti, A. H. (1998) · Blood · doi:10.1182/blood.v92.5.1785 · Cited by 42
Thrombosis in heritable hemolytic disorders
Barker, J. E., & Wandersee, N. J. (1999) · Current Opinion in Hematology · doi:10.1097/00062752-199903000-00003 · Cited by 35
A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major.
Eldor, A., Maclouf, J., Lellouche, F., Ben-Yashar, V., Barenholz, Y., Durst, R. Y., Hyam, E., Goldfarb, A. H., & Rachmilewitz, E. A. (1993) · PubMed · Cited by 35
Self-citation2 Haemoglobinopathies and red cell membrane function
Shinar, E., & Rachmilewitz, E. A. (1993) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80150-7 · Cited by 31
Self-citationWiener, E., Wanachiwanawin, W., Chinprasertsuk, S., Siripanyaphinyo, U., Mawas, F., Fucharoen, S., & Wickramasinghe, S. N. (1996) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1996.tb01394.x · Cited by 29
Venous Thrombosis in Haemoglobin H Disease After Splenectomy
Tso, S. C., Chan, T. K., & Todd, D. (1982) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1982.tb02655.x · Cited by 28
Stroke prevention in sickle cell disease
Adams, R. J. (2000) · Current Opinion in Hematology · doi:10.1097/00062752-200003000-00005 · Cited by 27
Foulon, I., Bachir, D., Galactéros, F., & Maclouf, J. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.3.421 · Cited by 26
Portal vein thrombosis in a child with homozygous sickle-cell disease.
Arnold, K. E., Char, G., & Serjeant, G. R. (1993) · PubMed · Cited by 25
Sickle Cell Disease and Stroke
Adams, R. J. (1995) · Journal of Child Neurology · doi:10.1177/088307389501000201 · Cited by 25
IFoulon, DBachir, FGalacteros, & JMaclouf (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · Cited by 17
Possible evolution of human parvovirus B19 infection into erythroleukemia.
Sitar, G., Balduini, C. L., Manenti, L., CASTELLO, A., Balanzin, D., & Ascari, E. (1999) · PubMed · Cited by 12
Cardiac dysfunction in beta-thalassemic children.
Chotivitayatarakorn, P., Seksarn, P., Pathmanand, C., Thisyakorn, C., & Sueblinvong, V. (1993) · PubMed · Cited by 10
Cited by
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319
Rund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
Self-citationCao, A., & Galanello, R. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181cd68ed · Cited by 722
Origa, R. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.173 · Cited by 509
Taher, A. T., Musallam, K. M., & Cappellini, M. D. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2021838 · Cited by 477
Metadata
- Authors
- Eldor, A., & Rachmilewitz, E. A.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-01-01
- Volume
- 99
- Issue
- 1
- Pages
- 36-43
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2005712358
- Cited by
- 503
- References
- 64
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.